MSI-1256F (Squalamine Lactate)

squalamine lactate · Genaera Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MSI-1256F (Squalamine Lactate), covering 2008-01-09 to 2008-01-09. Get the full timeline:

Most recent: Clinical Trial Update: MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) [Phase 2]

See pricing